Therapeutic potential of endothelin receptor antagonism in kidney disease.

about

Pulse-wave velocity is associated with cognitive impairment in haemodialysis patients.Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases.Atrasentan for the treatment of diabetic nephropathy.

P2860

Q38703896-AA4D2DB7-4F5C-47EA-A221-92044690D015 Q38759324-A93E054B-DEDF-41A0-9125-085F22537AF9 Q38806647-8D7CB354-1FD4-4952-BA3B-F967F2947A76

P2860

Therapeutic potential of endothelin receptor antagonism in kidney disease.

Item

http://www.wikidata.org/entity/Q38678678

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Therapeutic potential of endothelin receptor antagonism in kidney disease.

@en

type

Item

label

Therapeutic potential of endothelin receptor antagonism in kidney disease.

@en

prefLabel

Therapeutic potential of endothelin receptor antagonism in kidney disease.

@en

P1476

Therapeutic potential of endothelin receptor antagonism in kidney disease.

@en

P2093

Alicja Czopek

http://www.w3.org/2001/XMLSchema#string

David J Webb

http://www.w3.org/2001/XMLSchema#string

Neeraj Dhaun

http://www.w3.org/2001/XMLSchema#string

Rebecca Moorhouse

http://www.w3.org/2001/XMLSchema#string

P2860

The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes

Avosentan reduces albumin excretion in diabetics with macroalbuminuria

The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy

Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure

Endothelin mediates some of the renal actions of acutely administered angiotensin II

ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies

P304

R388-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPREGU.00478.2015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

310

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26702154

http://www.w3.org/2001/XMLSchema#string

Therapeutic potential of endothelin receptor antagonism in kidney disease.

about

P2860

P2860

Therapeutic potential of endothelin receptor antagonism in kidney disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698